These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21258152)

  • 21. Clinical, neuropathological, and genetic characteristics of the novel IVS9+1delG GRN mutation in a patient with frontotemporal dementia.
    Taipa R; Tuna A; Damásio J; Pinto PS; Cavaco S; Pereira S; Milterberger-Miltenyi G; Galimberti D; Melo-Pires M
    J Alzheimers Dis; 2012; 30(1):83-90. PubMed ID: 22366770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.
    Beck J; Rohrer JD; Campbell T; Isaacs A; Morrison KE; Goodall EF; Warrington EK; Stevens J; Revesz T; Holton J; Al-Sarraj S; King A; Scahill R; Warren JD; Fox NC; Rossor MN; Collinge J; Mead S
    Brain; 2008 Mar; 131(Pt 3):706-20. PubMed ID: 18234697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural brain signature of FTLD driven by Granulin mutation.
    Bozzali M; Battistoni V; Premi E; Alberici A; Giulietti G; Archetti S; Turla M; Gasparotti R; Cercignani M; Padovani A; Borroni B
    J Alzheimers Dis; 2013; 33(2):483-94. PubMed ID: 22986778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutation.
    Bruni AC; Momeni P; Bernardi L; Tomaino C; Frangipane F; Elder J; Kawarai T; Sato C; Pradella S; Wakutani Y; Anfossi M; Gallo M; Geracitano S; Costanzo A; Smirne N; Curcio SA; Mirabelli M; Puccio G; Colao R; Maletta RG; Kertesz A; St George-Hyslop P; Hardy J; Rogaeva E
    Neurology; 2007 Jul; 69(2):140-7. PubMed ID: 17620546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations.
    Van Deerlin VM; Wood EM; Moore P; Yuan W; Forman MS; Clark CM; Neumann M; Kwong LK; Trojanowski JQ; Lee VM; Grossman M
    Arch Neurol; 2007 Aug; 64(8):1148-53. PubMed ID: 17698705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GRN Thr272fs clinical heterogeneity: a case with atypical late onset presenting with a dementia with Lewy bodies phenotype.
    Arosio B; Abbate C; Galimberti D; Rossi PD; Inglese S; Fenoglio C; Ridolfi E; Gussago C; Casati M; Tedone E; Ferri E; Serpente M; Scarpini E; Mari D
    J Alzheimers Dis; 2013; 35(4):669-74. PubMed ID: 23478307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progranulin null mutations in both sporadic and familial frontotemporal dementia.
    Le Ber I; van der Zee J; Hannequin D; Gijselinck I; Campion D; Puel M; Laquerrière A; De Pooter T; Camuzat A; Van den Broeck M; Dubois B; Sellal F; Lacomblez L; Vercelletto M; Thomas-Antérion C; Michel BF; Golfier V; Didic M; Salachas F; Duyckaerts C; Cruts M; Verpillat P; Van Broeckhoven C; Brice A;
    Hum Mutat; 2007 Sep; 28(9):846-55. PubMed ID: 17436289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers.
    Galimberti D; Bonsi R; Fenoglio C; Serpente M; Cioffi SM; Fumagalli G; Arighi A; Ghezzi L; Arcaro M; Mercurio M; Rotondo E; Scarpini E
    Brain Behav Immun; 2015 Oct; 49():182-7. PubMed ID: 26021560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autosomal Dominant Frontotemporal Lobar Degeneration in a Filipino Family with Progranulin Mutation.
    Dominguez J; Ng A; Yu J; Guevarra AC; Daroy ML; Alfon A; Catindig JA; Dizon M; Santiago J; Del Moral MC; Yu J; Jamerlan A; Ligsay A; Bagyinszky E; An SS; Kim S
    Dement Geriatr Cogn Disord; 2020; 49(6):557-564. PubMed ID: 33486486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation.
    Boeve BF; Tremont-Lukats IW; Waclawik AJ; Murrell JR; Hermann B; Jack CR; Shiung MM; Smith GE; Nair AR; Lindor N; Koppikar V; Ghetti B
    Brain; 2005 Apr; 128(Pt 4):752-72. PubMed ID: 15615814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update.
    Gijselinck I; Van Broeckhoven C; Cruts M
    Hum Mutat; 2008 Dec; 29(12):1373-86. PubMed ID: 18543312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.
    Benussi L; Ghidoni R; Pegoiani E; Moretti DV; Zanetti O; Binetti G
    Neurobiol Dis; 2009 Mar; 33(3):379-85. PubMed ID: 19101631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
    Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M
    Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progranulin mutation causes frontotemporal dementia in the Swedish Karolinska family.
    Chiang HH; Rosvall L; Brohede J; Axelman K; Björk BF; Nennesmo I; Robins T; Graff C
    Alzheimers Dement; 2008 Nov; 4(6):414-20. PubMed ID: 19012866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study.
    Chen Q; Boeve BF; Senjem M; Tosakulwong N; Lesnick T; Brushaber D; Dheel C; Fields J; Forsberg L; Gavrilova R; Gearhart D; Graff-Radford J; Graff-Radford N; Jack CR; Jones D; Knopman D; Kremers WK; Lapid M; Rademakers R; Ramos EM; Syrjanen J; Boxer AL; Rosen H; Wszolek ZK; Kantarci K
    Neurobiol Aging; 2020 Apr; 88():42-50. PubMed ID: 31918955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.
    Oldoni E; Fumagalli GG; Serpente M; Fenoglio C; Scarioni M; Arighi A; Bruno G; Talarico G; Confaloni A; Piscopo P; Nacmias B; Sorbi S; Rainero I; Rubino E; Pinessi L; Binetti G; Ghidoni R; Benussi L; Grande G; Arosio B; Bursey D; Kauwe JS; Cioffi SM; Arcaro M; Mari D; Mariani C; Scarpini E; Galimberti D
    J Alzheimers Dis; 2016; 50(2):353-7. PubMed ID: 26757195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study.
    Milanesi E; Bonvicini C; Alberici A; Pilotto A; Cattane N; Premi E; Gazzina S; Archetti S; Gasparotti R; Cancelli V; Gennarelli M; Padovani A; Borroni B
    Neurobiol Aging; 2013 Jul; 34(7):1837-45. PubMed ID: 23419701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two cases of frontotemporal dementia with predominant temporal lobe atrophy.
    Shimizu H; Hokoishi K; Fukuhara R; Komori K; Ikeda M
    Psychogeriatrics; 2009 Dec; 9(4):204-7. PubMed ID: 20377822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics.
    Moreno F; Indakoetxea B; Barandiaran M; Caballero MC; Gorostidi A; Calafell F; Gabilondo A; Tainta M; Zulaica M; Martí Massó JF; López de Munain A; Sánchez-Juan P; Lee SE
    PLoS One; 2017; 12(6):e0178093. PubMed ID: 28594853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. White matter hyperintensities characterize monogenic frontotemporal dementia with granulin mutations.
    Paternicò D; Premi E; Gazzina S; Cosseddu M; Alberici A; Archetti S; Cotelli MS; Micheli A; Turla M; Gasparotti R; Padovani A; Borroni B
    Neurobiol Aging; 2016 Feb; 38():176-180. PubMed ID: 26827655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.